Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
3.500
+0.420 (13.64%)
Mar 4, 2026, 4:29 PM CET
443.48%
Market Cap 752.17M
Revenue (ttm) n/a
Net Income (ttm) -6.60M
Shares Out 214.91M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22,920,742
Average Volume 10,136,226
Open 3.235
Previous Close 3.080
Day's Range 3.080 - 3.635
52-Week Range 0.480 - 3.635
Beta 1.45
RSI 91.22
Earnings Date Apr 15, 2026

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.